Register entry
COMMAVE SUB LLC A WHOLLY OWNED SUB OF COLLEGIUM PHARMACEUTICAL INC
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 18
- Countries
- 0
Exclusivity
Patents and exclusivities
18| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 9079928 | AZSTARYSdexmethylphenidate hydrochloride; serdexmethylphenidate chloride | product | May 2035 |
| 10584112 | AZSTARYSdexmethylphenidate hydrochloride; serdexmethylphenidate chloride | substance, product | Dec 2037 |
| 10584113 | AZSTARYSdexmethylphenidate hydrochloride; serdexmethylphenidate chloride | product | Dec 2037 |
| 10759778 | AZSTARYSdexmethylphenidate hydrochloride; serdexmethylphenidate chloride | product | Dec 2037 |
| 10858341 | AZSTARYSdexmethylphenidate hydrochloride; serdexmethylphenidate chloride | use | Dec 2037 |
| 10954213 | AZSTARYSdexmethylphenidate hydrochloride; serdexmethylphenidate chloride | use | Dec 2037 |
Enquiry
Common questions
- Is COMMAVE SUB LLC A WHOLLY OWNED SUB OF COLLEGIUM PHARMACEUTICAL INC FDA approved?
- COMMAVE SUB LLC A WHOLLY OWNED SUB OF COLLEGIUM PHARMACEUTICAL INC holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.